These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura. Stasi R, Evangelista ML, Amadori S. Drugs; 2008; 68(7):901-12. PubMed ID: 18457458 [Abstract] [Full Text] [Related]
4. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Nurden AT, Viallard JF, Nurden P. Lancet; 2009 May 02; 373(9674):1562-9. PubMed ID: 19324405 [Abstract] [Full Text] [Related]
5. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Kuter DJ. Eur J Haematol Suppl; 2008 Feb 02; (69):9-18. PubMed ID: 18211568 [Abstract] [Full Text] [Related]
6. New options after first-line therapy for chronic immune thrombocytopenic purpura. Burzynski J. Am J Health Syst Pharm; 2009 Jan 15; 66(2 Suppl 2):S11-21. PubMed ID: 19139486 [Abstract] [Full Text] [Related]
7. Positioning new treatments in the management of immune thrombocytopenia. Arnold DM. Pediatr Blood Cancer; 2013 Jan 15; 60 Suppl 1(Suppl 1):S19-22. PubMed ID: 23109488 [Abstract] [Full Text] [Related]
9. Two new drugs for chronic ITP. Med Lett Drugs Ther; 2009 Feb 09; 51(1305):10-1. PubMed ID: 19197233 [Abstract] [Full Text] [Related]
10. New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Arnold DM, Nazi I, Kelton JG. Expert Opin Investig Drugs; 2009 Jun 09; 18(6):805-19. PubMed ID: 19426124 [Abstract] [Full Text] [Related]
13. [Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review]. Vizcaíno G, Diez-Ewald M, Vizcaíno-Carruyo J. Invest Clin; 2009 Mar 09; 50(1):95-108. PubMed ID: 19418731 [Abstract] [Full Text] [Related]
14. [Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?]. Godeau B, Centre de référence labellisé pour la prise en charge des cytopénies auto-immunes de l'adulte. Rev Med Interne; 2009 Mar 09; 30(3):203-5. PubMed ID: 19019500 [No Abstract] [Full Text] [Related]
15. Eltrombopag for the treatment of idiopathic thrombocytopenic purpura. Stasi R. Expert Rev Hematol; 2008 Dec 09; 1(2):145-52. PubMed ID: 21082919 [Abstract] [Full Text] [Related]
16. Current therapies in primary immune thrombocytopenia. Pels SG. Semin Thromb Hemost; 2011 Sep 09; 37(6):621-30. PubMed ID: 22102265 [Abstract] [Full Text] [Related]
17. Pathophysiology and management of primary immune thrombocytopenia. Kashiwagi H, Tomiyama Y. Int J Hematol; 2013 Jul 09; 98(1):24-33. PubMed ID: 23702914 [Abstract] [Full Text] [Related]
18. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura. Gernsheimer TB. Hematology Am Soc Hematol Educ Program; 2008 Jul 09; ():219-26. PubMed ID: 19074086 [Abstract] [Full Text] [Related]
19. New therapeutic options for immune thrombocytopenia. Schipperus M, Fijnheer R. Neth J Med; 2011 Jul 09; 69(11):480-5. PubMed ID: 22173361 [Abstract] [Full Text] [Related]
20. Current options for the treatment of idiopathic thrombocytopenic purpura. Arnold DM, Kelton JG. Semin Hematol; 2007 Oct 09; 44(4 Suppl 5):S12-23. PubMed ID: 18096468 [Abstract] [Full Text] [Related] Page: [Next] [New Search]